Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) ROCE %: 12.55% (As of Mar. 2026)


SHSE:605033 Shaanxi Meibang Pharmaceutical Group Co Ltd SHSE:605033
81 GF Score
Price ¥17.37
GF Value ¥22.13
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Shaanxi Meibang Pharmaceutical Group Co ROCE %?

Shaanxi Meibang Pharmaceutical Group Co SHSE:605033 +1.82% 81 ROCE % is 12.55% as of Mar. 2026. GuruFocus rates SHSE:605033 with a GF Score™ of 81/100 and a GF Value™ of ¥22.13 (Modestly Undervalued). The stock has 3 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shaanxi Meibang Pharmaceutical Group Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 12.55%.

Shaanxi Meibang Pharmaceutical Group Co  (SHSE:605033) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shaanxi Meibang Pharmaceutical Group Co ROCE % Related Terms

Shaanxi Meibang Pharmaceutical Group Co ROCE % Historical Data

* Premium members only.

The historical data trend for Shaanxi Meibang Pharmaceutical Group Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shaanxi Meibang Pharmaceutical Group Co ROCE % Chart

Shaanxi Meibang Pharmaceutical Group Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only 18.93 13.83 5.18 3.06 4.05

Shaanxi Meibang Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.00 0.44 -0.22 4.81 12.55
SHSE:605033
81GF Score
Shaanxi Meibang Pharmaceutical Group Co Ltd SHSE:605033
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shaanxi Meibang Pharmaceutical Group Co ROCE % Calculation

Shaanxi Meibang Pharmaceutical Group Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=52.771/( ( (1862.032 - 616.258) + (2068.131 - 705.261) )/ 2 )
=52.771/( (1245.774+1362.87)/ 2 )
=52.771/1304.322
=4.05 %

Shaanxi Meibang Pharmaceutical Group Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=180.772/( ( (2068.131 - 705.261) + (1969.988 - 451.189) )/ 2 )
=180.772/( ( 1362.87 + 1518.799 )/ 2 )
=180.772/1440.8345
=12.55 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 12.55% mean?
Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) has a ROCE % of 12.55% as of Mar. 2026.
Is Shaanxi Meibang Pharmaceutical Group Co's ROCE % too high?
Shaanxi Meibang Pharmaceutical Group Co's current ROCE % is 12.55%. The Agriculture industry median ROCE % is 9.43. Shaanxi Meibang Pharmaceutical Group Co's value of 12.55% is 33.1% above this industry median. Overall, Shaanxi Meibang Pharmaceutical Group Co has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shaanxi Meibang Pharmaceutical Group Co's ROCE % compare to CTVA and CF?
Shaanxi Meibang Pharmaceutical Group Co's ROCE % of 12.55% can be compared against companies in the Agriculture industry. The industry median ROCE % is 9.43. Shaanxi Meibang Pharmaceutical Group Co's value of 12.55% is 33.1% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for an Agriculture company?
The median ROCE % among Agriculture companies is 9.43, based on 253 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shaanxi Meibang Pharmaceutical Group Co's current ROCE % of 12.55% is 33.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Agriculture industry, the median ROCE % is 9.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shaanxi Meibang Pharmaceutical Group Co's current ROCE % is 12.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shaanxi Meibang Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥22.13, compared to a current price of ¥17.37 — trading 21.5% below its estimated fair value. The current ROCE % is 12.55% and 33.1% above the Agriculture industry median of 9.43. Shaanxi Meibang Pharmaceutical Group Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033), the current ROCE % is 12.55% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shaanxi Meibang Pharmaceutical Group Co (SHSE:605033) Overvalued in 2026?

Based on GuruFocus' analysis, Shaanxi Meibang Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥17.37 is trading 21.5% below its estimated GF Value™ of ¥22.13. GuruFocus considers Shaanxi Meibang Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:605033:

  • ROCE %: 12.55%
  • GF Value™: ¥22.13 vs. price of ¥17.37 (21.5% below fair value)
  • GF Score™: 81/100 with 3 warning signs
  • Industry Position: 33.1% above the Agriculture median

No single metric tells the full story. See the SHSE:605033 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Shaanxi Meibang Pharmaceutical Group Co Business Description

Address High-tech Industrial Development Zone, Pucheng County, Shaanxi Province, Weinan, CHN, 715500
Shaanxi Meibang Pharmaceutical Group Co Ltd is engaged in the research and development, production and sales of pesticide formulations.
81GF Score

Get the complete analysis for SHSE:605033

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥17.37
Price
¥22.13
GF Value